nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—testicular cancer—adrenal gland cancer	0.26	0.355	CtDrD
Methotrexate—germ cell cancer—adrenal gland cancer	0.249	0.34	CtDrD
Methotrexate—lung cancer—adrenal gland cancer	0.224	0.305	CtDrD
Methotrexate—ABCB1—adrenal gland cancer	0.163	1	CbGaD
Methotrexate—SLC22A8—urine—adrenal gland cancer	0.00183	0.0431	CbGeAlD
Methotrexate—FOLR1—pituitary gland—adrenal gland cancer	0.00152	0.0358	CbGeAlD
Methotrexate—ABCC11—gonad—adrenal gland cancer	0.0015	0.0352	CbGeAlD
Methotrexate—SLC19A1—gonad—adrenal gland cancer	0.00137	0.0322	CbGeAlD
Methotrexate—SLC46A1—adrenal cortex—adrenal gland cancer	0.00127	0.0299	CbGeAlD
Methotrexate—SLC19A1—adrenal gland—adrenal gland cancer	0.00119	0.028	CbGeAlD
Methotrexate—FPGS—adrenal cortex—adrenal gland cancer	0.0011	0.0259	CbGeAlD
Methotrexate—GGH—gonad—adrenal gland cancer	0.00104	0.0244	CbGeAlD
Methotrexate—SLC46A1—pituitary gland—adrenal gland cancer	0.00103	0.0242	CbGeAlD
Methotrexate—GGH—pituitary gland—adrenal gland cancer	0.00101	0.0238	CbGeAlD
Methotrexate—SLC46A1—adrenal gland—adrenal gland cancer	0.00092	0.0216	CbGeAlD
Methotrexate—FPGS—cardiac atrium—adrenal gland cancer	0.000911	0.0214	CbGeAlD
Methotrexate—GGH—adrenal gland—adrenal gland cancer	0.000905	0.0213	CbGeAlD
Methotrexate—FPGS—pituitary gland—adrenal gland cancer	0.00089	0.0209	CbGeAlD
Methotrexate—ATIC—gonad—adrenal gland cancer	0.000883	0.0207	CbGeAlD
Methotrexate—SLCO1B3—pituitary gland—adrenal gland cancer	0.000873	0.0205	CbGeAlD
Methotrexate—FPGS—adrenal gland—adrenal gland cancer	0.000795	0.0187	CbGeAlD
Methotrexate—ATIC—adrenal gland—adrenal gland cancer	0.000769	0.0181	CbGeAlD
Methotrexate—SLCO1C1—pituitary gland—adrenal gland cancer	0.000716	0.0168	CbGeAlD
Methotrexate—DHFR—adrenal cortex—adrenal gland cancer	0.000716	0.0168	CbGeAlD
Methotrexate—PGD—adrenal cortex—adrenal gland cancer	0.000688	0.0162	CbGeAlD
Methotrexate—SLCO3A1—gonad—adrenal gland cancer	0.000645	0.0152	CbGeAlD
Methotrexate—SLCO3A1—cardiac atrium—adrenal gland cancer	0.000645	0.0151	CbGeAlD
Methotrexate—SLCO3A1—pituitary gland—adrenal gland cancer	0.00063	0.0148	CbGeAlD
Methotrexate—AOX1—adrenal cortex—adrenal gland cancer	0.000606	0.0142	CbGeAlD
Methotrexate—TYMS—gonad—adrenal gland cancer	0.000599	0.0141	CbGeAlD
Methotrexate—ABCC3—adrenal cortex—adrenal gland cancer	0.000593	0.0139	CbGeAlD
Methotrexate—DHFR—gonad—adrenal gland cancer	0.000593	0.0139	CbGeAlD
Methotrexate—DHFR—cardiac atrium—adrenal gland cancer	0.000592	0.0139	CbGeAlD
Methotrexate—ABCC10—adrenal cortex—adrenal gland cancer	0.00059	0.0139	CbGeAlD
Methotrexate—DHFR—pituitary gland—adrenal gland cancer	0.000578	0.0136	CbGeAlD
Methotrexate—MTHFR—adrenal gland—adrenal gland cancer	0.000572	0.0134	CbGeAlD
Methotrexate—PGD—gonad—adrenal gland cancer	0.00057	0.0134	CbGeAlD
Methotrexate—PGD—cardiac atrium—adrenal gland cancer	0.000569	0.0134	CbGeAlD
Methotrexate—SLCO3A1—adrenal gland—adrenal gland cancer	0.000563	0.0132	CbGeAlD
Methotrexate—PGD—pituitary gland—adrenal gland cancer	0.000556	0.0131	CbGeAlD
Methotrexate—SLC16A1—gonad—adrenal gland cancer	0.000532	0.0125	CbGeAlD
Methotrexate—SLC16A1—cardiac atrium—adrenal gland cancer	0.000531	0.0125	CbGeAlD
Methotrexate—TYMS—adrenal gland—adrenal gland cancer	0.000522	0.0123	CbGeAlD
Methotrexate—SLC16A1—pituitary gland—adrenal gland cancer	0.000519	0.0122	CbGeAlD
Methotrexate—DHFR—adrenal gland—adrenal gland cancer	0.000516	0.0121	CbGeAlD
Methotrexate—AOX1—gonad—adrenal gland cancer	0.000502	0.0118	CbGeAlD
Methotrexate—AOX1—cardiac atrium—adrenal gland cancer	0.000501	0.0118	CbGeAlD
Methotrexate—PGD—adrenal gland—adrenal gland cancer	0.000497	0.0117	CbGeAlD
Methotrexate—AOX1—pituitary gland—adrenal gland cancer	0.00049	0.0115	CbGeAlD
Methotrexate—ABCC10—gonad—adrenal gland cancer	0.000489	0.0115	CbGeAlD
Methotrexate—ABCC10—cardiac atrium—adrenal gland cancer	0.000488	0.0115	CbGeAlD
Methotrexate—ABCC10—pituitary gland—adrenal gland cancer	0.000477	0.0112	CbGeAlD
Methotrexate—SLC16A1—adrenal gland—adrenal gland cancer	0.000464	0.0109	CbGeAlD
Methotrexate—AOX1—adrenal gland—adrenal gland cancer	0.000437	0.0103	CbGeAlD
Methotrexate—ABCC3—adrenal gland—adrenal gland cancer	0.000428	0.0101	CbGeAlD
Methotrexate—ABCC10—adrenal gland—adrenal gland cancer	0.000426	0.01	CbGeAlD
Methotrexate—ABCC1—adrenal cortex—adrenal gland cancer	0.000417	0.0098	CbGeAlD
Methotrexate—ALB—adrenal gland—adrenal gland cancer	0.000365	0.00857	CbGeAlD
Methotrexate—ABCC4—adrenal gland—adrenal gland cancer	0.000353	0.0083	CbGeAlD
Methotrexate—ABCG2—adrenal cortex—adrenal gland cancer	0.000345	0.00811	CbGeAlD
Methotrexate—ABCC1—cardiac atrium—adrenal gland cancer	0.000345	0.00811	CbGeAlD
Methotrexate—ABCC2—adrenal gland—adrenal gland cancer	0.000342	0.00803	CbGeAlD
Methotrexate—ABCC1—pituitary gland—adrenal gland cancer	0.000337	0.00792	CbGeAlD
Methotrexate—ABCC1—adrenal gland—adrenal gland cancer	0.000301	0.00708	CbGeAlD
Methotrexate—ABCG2—pituitary gland—adrenal gland cancer	0.000279	0.00656	CbGeAlD
Methotrexate—ABCG2—adrenal gland—adrenal gland cancer	0.000249	0.00586	CbGeAlD
Methotrexate—ABCB1—adrenal cortex—adrenal gland cancer	0.00017	0.004	CbGeAlD
Methotrexate—ABCB1—gonad—adrenal gland cancer	0.000141	0.00331	CbGeAlD
Methotrexate—ABCB1—pituitary gland—adrenal gland cancer	0.000138	0.00323	CbGeAlD
Methotrexate—ABCB1—adrenal gland—adrenal gland cancer	0.000123	0.00289	CbGeAlD
Methotrexate—ABCC1—Disease—ZNRF3—adrenal gland cancer	4e-05	0.000654	CbGpPWpGaD
Methotrexate—FPGS—Disease—BRAF—adrenal gland cancer	4e-05	0.000653	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—POMC—adrenal gland cancer	3.99e-05	0.000652	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—SDHB—adrenal gland cancer	3.98e-05	0.000651	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—TERT—adrenal gland cancer	3.93e-05	0.000643	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	3.93e-05	0.000642	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—GNAS—adrenal gland cancer	3.92e-05	0.000641	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—MED12—adrenal gland cancer	3.91e-05	0.000639	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—ABCB1—adrenal gland cancer	3.85e-05	0.000629	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—RRM1—adrenal gland cancer	3.82e-05	0.000624	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—SDHD—adrenal gland cancer	3.82e-05	0.000624	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—PTGS2—adrenal gland cancer	3.8e-05	0.000621	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	3.79e-05	0.000619	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	3.76e-05	0.000615	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	3.76e-05	0.000614	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	3.71e-05	0.000607	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—SDHB—adrenal gland cancer	3.69e-05	0.000603	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—CDC42—adrenal gland cancer	3.69e-05	0.000603	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	3.67e-05	0.000599	CbGpPWpGaD
Methotrexate—PGD—Disease—TERT—adrenal gland cancer	3.6e-05	0.000588	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	3.6e-05	0.000588	CbGpPWpGaD
Methotrexate—PGD—Metabolism—GNAS—adrenal gland cancer	3.59e-05	0.000586	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—TERT—adrenal gland cancer	3.59e-05	0.000586	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle, Mitotic—RB1—adrenal gland cancer	3.58e-05	0.000585	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—MED12—adrenal gland cancer	3.56e-05	0.000582	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—IGF2—adrenal gland cancer	3.55e-05	0.000581	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	3.53e-05	0.000577	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—GNAS—adrenal gland cancer	3.52e-05	0.000576	CbGpPWpGaD
Methotrexate—PGD—Metabolism—ABCB1—adrenal gland cancer	3.52e-05	0.000576	CbGpPWpGaD
Methotrexate—MTHFR—Disease—PRKACA—adrenal gland cancer	3.49e-05	0.00057	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	3.49e-05	0.00057	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	3.47e-05	0.000567	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—SDHD—adrenal gland cancer	3.45e-05	0.000563	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—RRM1—adrenal gland cancer	3.45e-05	0.000563	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—BAD—adrenal gland cancer	3.42e-05	0.000559	CbGpPWpGaD
Methotrexate—AOX1—Disease—PRKACA—adrenal gland cancer	3.41e-05	0.000557	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—CTNNB1—adrenal gland cancer	3.4e-05	0.000555	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—POMC—adrenal gland cancer	3.39e-05	0.000554	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—POMC—adrenal gland cancer	3.39e-05	0.000554	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	3.3e-05	0.000539	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	3.28e-05	0.000535	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	3.24e-05	0.00053	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—MED12—adrenal gland cancer	3.24e-05	0.00053	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	3.24e-05	0.000529	CbGpPWpGaD
Methotrexate—FPGS—Disease—PTGS2—adrenal gland cancer	3.23e-05	0.000528	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—RB1—adrenal gland cancer	3.2e-05	0.000523	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	3.18e-05	0.00052	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	3.18e-05	0.00052	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—PTGS2—adrenal gland cancer	3.18e-05	0.00052	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	3.17e-05	0.000519	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	3.16e-05	0.000516	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	3.15e-05	0.000514	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	3.14e-05	0.000513	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	3.13e-05	0.000512	CbGpPWpGaD
Methotrexate—PGD—Disease—BAD—adrenal gland cancer	3.13e-05	0.000511	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle, Mitotic—RB1—adrenal gland cancer	3.12e-05	0.00051	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	3.12e-05	0.00051	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	3.12e-05	0.00051	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—BRAF—adrenal gland cancer	3.12e-05	0.000509	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—MED12—adrenal gland cancer	3.1e-05	0.000507	CbGpPWpGaD
Methotrexate—DHFR—Disease—PRKACA—adrenal gland cancer	3.1e-05	0.000507	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	3.05e-05	0.000499	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—TP53—adrenal gland cancer	3.03e-05	0.000495	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—RRM1—adrenal gland cancer	3e-05	0.000491	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—SDHD—adrenal gland cancer	3e-05	0.000491	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	2.99e-05	0.000489	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	2.98e-05	0.000487	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CDC42—adrenal gland cancer	2.96e-05	0.000484	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PRKACA—adrenal gland cancer	2.92e-05	0.000477	CbGpPWpGaD
Methotrexate—AOX1—Disease—CDC42—adrenal gland cancer	2.89e-05	0.000472	CbGpPWpGaD
Methotrexate—FPGS—Disease—CTNNB1—adrenal gland cancer	2.89e-05	0.000472	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PRKACA—adrenal gland cancer	2.85e-05	0.000466	CbGpPWpGaD
Methotrexate—PGD—Disease—BRAF—adrenal gland cancer	2.85e-05	0.000466	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—MED12—adrenal gland cancer	2.85e-05	0.000465	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	2.83e-05	0.000462	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—CDKN2A—adrenal gland cancer	2.81e-05	0.00046	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—RB1—adrenal gland cancer	2.79e-05	0.000456	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	2.77e-05	0.000453	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	2.76e-05	0.000451	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	2.74e-05	0.000449	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—PTGS2—adrenal gland cancer	2.7e-05	0.000442	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—PTGS2—adrenal gland cancer	2.7e-05	0.000442	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—RRM1—adrenal gland cancer	2.7e-05	0.000441	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—SDHD—adrenal gland cancer	2.7e-05	0.000441	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—EGFR—adrenal gland cancer	2.69e-05	0.00044	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	2.66e-05	0.000434	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—POMC—adrenal gland cancer	2.64e-05	0.000432	CbGpPWpGaD
Methotrexate—DHFR—Disease—CDC42—adrenal gland cancer	2.63e-05	0.00043	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	2.61e-05	0.000426	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—TP53—adrenal gland cancer	2.6e-05	0.000425	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PRKACA—adrenal gland cancer	2.6e-05	0.000424	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	2.57e-05	0.00042	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—MED12—adrenal gland cancer	2.57e-05	0.00042	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—RRM1—adrenal gland cancer	2.57e-05	0.000419	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—SDHD—adrenal gland cancer	2.57e-05	0.000419	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.55e-05	0.000416	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	2.54e-05	0.000415	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	2.52e-05	0.000412	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—PTGS2—adrenal gland cancer	2.52e-05	0.000411	CbGpPWpGaD
Methotrexate—ABCC1—Disease—SPRY2—adrenal gland cancer	2.51e-05	0.00041	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	2.49e-05	0.000408	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	2.46e-05	0.000401	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—CDKN2A—adrenal gland cancer	2.45e-05	0.000401	CbGpPWpGaD
Methotrexate—PGD—Metabolism—POMC—adrenal gland cancer	2.42e-05	0.000395	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	2.42e-05	0.000395	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—SDHD—adrenal gland cancer	2.38e-05	0.000388	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—RRM1—adrenal gland cancer	2.38e-05	0.000388	CbGpPWpGaD
Methotrexate—MTHFR—Disease—TERT—adrenal gland cancer	2.37e-05	0.000388	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	2.37e-05	0.000387	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—GNAS—adrenal gland cancer	2.37e-05	0.000387	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PRKACA—adrenal gland cancer	2.36e-05	0.000386	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—SPARC—adrenal gland cancer	2.33e-05	0.000381	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—ABCB1—adrenal gland cancer	2.32e-05	0.00038	CbGpPWpGaD
Methotrexate—AOX1—Disease—TERT—adrenal gland cancer	2.32e-05	0.000379	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—GNAS—adrenal gland cancer	2.31e-05	0.000378	CbGpPWpGaD
Methotrexate—PGD—Disease—PTGS2—adrenal gland cancer	2.3e-05	0.000376	CbGpPWpGaD
Methotrexate—ABCC1—Disease—MEN1—adrenal gland cancer	2.3e-05	0.000376	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.3e-05	0.000375	CbGpPWpGaD
Methotrexate—FPGS—Disease—EGFR—adrenal gland cancer	2.29e-05	0.000374	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SDHB—adrenal gland cancer	2.28e-05	0.000372	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—ABCB1—adrenal gland cancer	2.27e-05	0.000371	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PRKACA—adrenal gland cancer	2.27e-05	0.00037	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—CTNNB1—adrenal gland cancer	2.25e-05	0.000368	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—MED12—adrenal gland cancer	2.24e-05	0.000366	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	2.24e-05	0.000366	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	2.22e-05	0.000364	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	2.2e-05	0.000359	CbGpPWpGaD
Methotrexate—DHFR—Disease—TERT—adrenal gland cancer	2.11e-05	0.000345	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—PTGS2—adrenal gland cancer	2.11e-05	0.000344	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—GNAS—adrenal gland cancer	2.1e-05	0.000344	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PRKACA—adrenal gland cancer	2.08e-05	0.00034	CbGpPWpGaD
Methotrexate—MTHFR—Disease—BAD—adrenal gland cancer	2.06e-05	0.000337	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—ABCB1—adrenal gland cancer	2.06e-05	0.000337	CbGpPWpGaD
Methotrexate—PGD—Disease—CTNNB1—adrenal gland cancer	2.06e-05	0.000337	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.03e-05	0.000332	CbGpPWpGaD
Methotrexate—AOX1—Disease—BAD—adrenal gland cancer	2.02e-05	0.00033	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—MED12—adrenal gland cancer	2.01e-05	0.000329	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2e-05	0.000327	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SDHB—adrenal gland cancer	1.99e-05	0.000326	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—PRKACA—adrenal gland cancer	1.97e-05	0.000322	CbGpPWpGaD
Methotrexate—PGD—Metabolism—PTGS2—adrenal gland cancer	1.93e-05	0.000315	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—GNAS—adrenal gland cancer	1.92e-05	0.000313	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—MED12—adrenal gland cancer	1.91e-05	0.000313	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—ABCB1—adrenal gland cancer	1.88e-05	0.000307	CbGpPWpGaD
Methotrexate—MTHFR—Disease—BRAF—adrenal gland cancer	1.88e-05	0.000307	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PRKACA—adrenal gland cancer	1.87e-05	0.000306	CbGpPWpGaD
Methotrexate—AOX1—Disease—BRAF—adrenal gland cancer	1.84e-05	0.0003	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GNAS—adrenal gland cancer	1.84e-05	0.0003	CbGpPWpGaD
Methotrexate—DHFR—Disease—BAD—adrenal gland cancer	1.83e-05	0.0003	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.83e-05	0.000299	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—ABCB1—adrenal gland cancer	1.8e-05	0.000294	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.8e-05	0.000294	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	1.79e-05	0.000293	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—EGFR—adrenal gland cancer	1.78e-05	0.000291	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—MED12—adrenal gland cancer	1.77e-05	0.00029	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PRKACA—adrenal gland cancer	1.75e-05	0.000287	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.71e-05	0.00028	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	1.7e-05	0.000278	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GNAS—adrenal gland cancer	1.68e-05	0.000275	CbGpPWpGaD
Methotrexate—DHFR—Disease—BRAF—adrenal gland cancer	1.67e-05	0.000273	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—CDC42—adrenal gland cancer	1.67e-05	0.000273	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—ABCB1—adrenal gland cancer	1.65e-05	0.00027	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	1.64e-05	0.000267	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PRKACA—adrenal gland cancer	1.63e-05	0.000267	CbGpPWpGaD
Methotrexate—PGD—Disease—EGFR—adrenal gland cancer	1.63e-05	0.000267	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IGF2—adrenal gland cancer	1.61e-05	0.000263	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.6e-05	0.000261	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—GNAS—adrenal gland cancer	1.59e-05	0.000261	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—POMC—adrenal gland cancer	1.59e-05	0.000261	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—TP53—adrenal gland cancer	1.57e-05	0.000256	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—POMC—adrenal gland cancer	1.56e-05	0.000254	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GNAS—adrenal gland cancer	1.52e-05	0.000248	CbGpPWpGaD
Methotrexate—MTHFR—Disease—PTGS2—adrenal gland cancer	1.52e-05	0.000248	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—TP53—adrenal gland cancer	1.51e-05	0.000247	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	1.49e-05	0.000244	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ABCB1—adrenal gland cancer	1.49e-05	0.000244	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CDC42—adrenal gland cancer	1.49e-05	0.000243	CbGpPWpGaD
Methotrexate—AOX1—Disease—PTGS2—adrenal gland cancer	1.48e-05	0.000242	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PRKACA—adrenal gland cancer	1.47e-05	0.00024	CbGpPWpGaD
Methotrexate—ALB—Metabolism—RRM1—adrenal gland cancer	1.47e-05	0.00024	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SDHD—adrenal gland cancer	1.47e-05	0.00024	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	1.46e-05	0.000239	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.44e-05	0.000235	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—POMC—adrenal gland cancer	1.42e-05	0.000232	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PRKACA—adrenal gland cancer	1.4e-05	0.000228	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	1.38e-05	0.000226	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—TP53—adrenal gland cancer	1.37e-05	0.000223	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.36e-05	0.000223	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CTNNB1—adrenal gland cancer	1.36e-05	0.000222	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	1.35e-05	0.000221	CbGpPWpGaD
Methotrexate—DHFR—Disease—PTGS2—adrenal gland cancer	1.35e-05	0.00022	CbGpPWpGaD
Methotrexate—AOX1—Disease—CTNNB1—adrenal gland cancer	1.33e-05	0.000217	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GNAS—adrenal gland cancer	1.32e-05	0.000216	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ABCB1—adrenal gland cancer	1.3e-05	0.000212	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PRKACA—adrenal gland cancer	1.29e-05	0.000211	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—POMC—adrenal gland cancer	1.29e-05	0.000211	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SDHD—adrenal gland cancer	1.28e-05	0.00021	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—RRM1—adrenal gland cancer	1.28e-05	0.00021	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PTGS2—adrenal gland cancer	1.27e-05	0.000208	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PTGS2—adrenal gland cancer	1.24e-05	0.000203	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—POMC—adrenal gland cancer	1.24e-05	0.000202	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	1.21e-05	0.000198	CbGpPWpGaD
Methotrexate—DHFR—Disease—CTNNB1—adrenal gland cancer	1.21e-05	0.000197	CbGpPWpGaD
Methotrexate—ABCC1—Disease—TERT—adrenal gland cancer	1.19e-05	0.000195	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GNAS—adrenal gland cancer	1.19e-05	0.000195	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ABCB1—adrenal gland cancer	1.17e-05	0.000191	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	1.16e-05	0.00019	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—POMC—adrenal gland cancer	1.13e-05	0.000185	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GNAS—adrenal gland cancer	1.13e-05	0.000185	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PTGS2—adrenal gland cancer	1.13e-05	0.000185	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—TP53—adrenal gland cancer	1.13e-05	0.000184	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ABCB1—adrenal gland cancer	1.11e-05	0.000181	CbGpPWpGaD
Methotrexate—ALB—Metabolism—MED12—adrenal gland cancer	1.09e-05	0.000179	CbGpPWpGaD
Methotrexate—MTHFR—Disease—EGFR—adrenal gland cancer	1.08e-05	0.000176	CbGpPWpGaD
Methotrexate—AOX1—Disease—EGFR—adrenal gland cancer	1.05e-05	0.000172	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GNAS—adrenal gland cancer	1.05e-05	0.000171	CbGpPWpGaD
Methotrexate—ABCC1—Disease—BAD—adrenal gland cancer	1.04e-05	0.00017	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PTGS2—adrenal gland cancer	1.03e-05	0.000168	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ABCB1—adrenal gland cancer	1.03e-05	0.000168	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—POMC—adrenal gland cancer	1.02e-05	0.000167	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PTGS2—adrenal gland cancer	9.86e-06	0.000161	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	9.77e-06	0.00016	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	9.74e-06	0.000159	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—MED12—adrenal gland cancer	9.58e-06	0.000157	CbGpPWpGaD
Methotrexate—DHFR—Disease—EGFR—adrenal gland cancer	9.56e-06	0.000156	CbGpPWpGaD
Methotrexate—ABCC1—Disease—BRAF—adrenal gland cancer	9.45e-06	0.000154	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PTGS2—adrenal gland cancer	9.04e-06	0.000148	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—POMC—adrenal gland cancer	8.91e-06	0.000146	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PTGS2—adrenal gland cancer	8.16e-06	0.000133	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—POMC—adrenal gland cancer	8.02e-06	0.000131	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PRKACA—adrenal gland cancer	7.98e-06	0.00013	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	7.8e-06	0.000127	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PTGS2—adrenal gland cancer	7.64e-06	0.000125	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—POMC—adrenal gland cancer	7.62e-06	0.000125	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PTGS2—adrenal gland cancer	7.11e-06	0.000116	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—POMC—adrenal gland cancer	7.05e-06	0.000115	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PRKACA—adrenal gland cancer	6.99e-06	0.000114	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CTNNB1—adrenal gland cancer	6.83e-06	0.000112	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GNAS—adrenal gland cancer	6.47e-06	0.000106	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PTGS2—adrenal gland cancer	6.39e-06	0.000105	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ABCB1—adrenal gland cancer	6.34e-06	0.000104	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PTGS2—adrenal gland cancer	6.08e-06	9.93e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GNAS—adrenal gland cancer	5.66e-06	9.26e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PTGS2—adrenal gland cancer	5.63e-06	9.2e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—EGFR—adrenal gland cancer	5.41e-06	8.85e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TP53—adrenal gland cancer	5.1e-06	8.33e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—POMC—adrenal gland cancer	4.35e-06	7.11e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—POMC—adrenal gland cancer	3.81e-06	6.23e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PTGS2—adrenal gland cancer	3.47e-06	5.67e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PTGS2—adrenal gland cancer	3.04e-06	4.97e-05	CbGpPWpGaD
